诺和诺德盘前升逾2% 高盛称司美格鲁肽口服制剂有望在短期内提振市场情绪

金吾资讯
Jan 22

金吾财讯 | 诺和诺德(NVO)盘前股价上扬,暂升2.09%,报60.56美元。高盛指出,公司近期推出的司美格鲁肽口服制剂有望在短期内提振市场情绪。高盛指出,上半年的市场焦点将集中于诺和诺德司美格鲁肽口服制剂,以及礼来制药的竞品口服药奥福格列肽的上市进展。高盛表示,司美格鲁肽口服制剂应当会在短期内为诺和诺德带来积极的盈利增长动能。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10